THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX)(PCX:RPRX) announced that it will host a Research and Development Day for the financial community beginning at 12:30pm Eastern Time on Thursday, January 4, 2007 in New York City. The event, which is by invitation only, will focus on Repros’ clinical drug candidates, Proellex™ and Androxal™. Scheduled speakers include:
